Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. by Farrell DJ, Sader HS, Castanheira M, Biedenbach DJ, Rhomberg PR and Jones RN published in Int. J. Antimicrob. Agents 2010; 35 (6): 537-543